According to the latest filing with the U.S. Securities and Exchange Commission (SEC), the biopharmaceutical company Immunic, Inc. has initiated an equity resale program.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Market Chatter: Brighthouse Financial's Acquisition by Sixth Street Resurrected as Aquarian Deal Delayed
Under the dual pressure of energy and political risks, the euro has fallen to a near two-month low, with 60% of options traders betting on further weakening.
After the Federal Reserve raised interest rates, the euro fell to a nearly two-month low, with about 60% of options bets anticipating further weakness; energy concerns and political risks in Germany and France are adding pressure. Morgan Stanley is bearish, while Deutsche Bank expects the euro to fluctuate within a range.
